Impact of anesthesia and analgesia techniques on glioblastoma progression. A narrative review

Glioblastoma (GBM) is an aggressive malignant CNS tumor with a median survival of 15 months after diagnosis. Standard therapy for GBM includes surgical resection, radiation, and temozolomide. Recently, anesthetics and analgesics have received attention for their potential involvement in mediating tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Privorotskiy, Ann, Bhavsar, Shreyas P, Lang, Frederick F, Hu, Jian, Cata, Juan P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653686/
https://www.ncbi.nlm.nih.gov/pubmed/33205044
http://dx.doi.org/10.1093/noajnl/vdaa123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653686/
https://www.ncbi.nlm.nih.gov/pubmed/33205044
http://dx.doi.org/10.1093/noajnl/vdaa123

Ejemplares similares